Maria Isabel is a Partner and head of the IP Regulatory Department at Bristows LLP. She specialises in European and UK regulatory and competition law in the bio-pharmaceutical and medical devices sectors.
 

She advises on a broad spectrum of matters, both contentious and noncontentious,
that arise in the conduct of a pharmaceutical or a biotechnology business. In particular, Marie represents leading bio-pharma companies in litigation before the English and EU courts. Recently, Marie successfully represented both Laboratoires CTRS before the General Court in relation to the Commission’s refusal to grant a marketing authorisation for an orphan medicinal product (Case T-301/12); and Seattle Genetics Inc. in an SPC case before the Court of Justice (C-471/12); as well as Shire Pharmaceuticals which secured a Paediatric extension. Marie also regularly co-ordinates EU and overseas litigation. Marie is also representing Les Laboratoires Servier against a decision of the EU Commission for breach of competition rules, as well as representing them in a damage action before the English Courts.
 

Marie also represents pharma companies before UK and EU institutions (EMA, MHRA, NICE, PMCPA DOH and the European Commission). For example, Marie successfully represented Clinuvel Pharmaceuticals before the EMA in relation to their application for SCENESSE®, a breakthrough drug. Marie is Chairperson of the Legal Affairs Community for DIA. Marie is considered as a leading practitioner for regulatory law and is described by clients as a “regulatory superstar”. She is recommended in Legal 500, Chambers and Partners; also London Top 100 & London Top 50Women and EU Law & Super Lawyers UK (2013).

Maria Isabel is a Partner and head of the IP Regulatory Department at Bristows LLP. She specialises in European and UK regulatory and competition law in the bio-pharmaceutical and medical devices sectors.
 

She advises on a broad spectrum of matters, both contentious and noncontentious,
that arise in the conduct of a pharmaceutical or a biotechnology business. In particular, Marie represents leading bio-pharma companies in litigation before the English and EU courts. Recently, Marie successfully represented both Laboratoires CTRS before the General Court in relation to the Commission’s refusal to grant a marketing authorisation for an orphan medicinal product (Case T-301/12); and Seattle Genetics Inc. in an SPC case before the Court of Justice (C-471/12); as well as Shire Pharmaceuticals which secured a Paediatric extension. Marie also regularly co-ordinates EU and overseas litigation. Marie is also representing Les Laboratoires Servier against a decision of the EU Commission for breach of competition rules, as well as representing them in a damage action before the English Courts.
 

Marie also represents pharma companies before UK and EU institutions (EMA, MHRA, NICE, PMCPA DOH and the European Commission). For example, Marie successfully represented Clinuvel Pharmaceuticals before the EMA in relation to their application for SCENESSE®, a breakthrough drug. Marie is Chairperson of the Legal Affairs Community for DIA. Marie is considered as a leading practitioner for regulatory law and is described by clients as a “regulatory superstar”. She is recommended in Legal 500, Chambers and Partners; also London Top 100 & London Top 50Women and EU Law & Super Lawyers UK (2013).

Maria Isabel is a Partner and head of the IP Regulatory Department at Bristows LLP. She specialises in European and UK regulatory and competition law in the bio-pharmaceutical and medical devices sectors.
 

She advises on a broad spectrum of matters, both contentious and noncontentious,
that arise in the conduct of a pharmaceutical or a biotechnology business. In particular, Marie represents leading bio-pharma companies in litigation before the English and EU courts. Recently, Marie successfully represented both Laboratoires CTRS before the General Court in relation to the Commission’s refusal to grant a marketing authorisation for an orphan medicinal product (Case T-301/12); and Seattle Genetics Inc. in an SPC case before the Court of Justice (C-471/12); as well as Shire Pharmaceuticals which secured a Paediatric extension. Marie also regularly co-ordinates EU and overseas litigation. Marie is also representing Les Laboratoires Servier against a decision of the EU Commission for breach of competition rules, as well as representing them in a damage action before the English Courts.
 

Marie also represents pharma companies before UK and EU institutions (EMA, MHRA, NICE, PMCPA DOH and the European Commission). For example, Marie successfully represented Clinuvel Pharmaceuticals before the EMA in relation to their application for SCENESSE®, a breakthrough drug. Marie is Chairperson of the Legal Affairs Community for DIA. Marie is considered as a leading practitioner for regulatory law and is described by clients as a “regulatory superstar”. She is recommended in Legal 500, Chambers and Partners; also London Top 100 & London Top 50Women and EU Law & Super Lawyers UK (2013).

Maria Isabel is a Partner and head of the IP Regulatory Department at Bristows LLP. She specialises in European and UK regulatory and competition law in the bio-pharmaceutical and medical devices sectors.
 

She advises on a broad spectrum of matters, both contentious and noncontentious,
that arise in the conduct of a pharmaceutical or a biotechnology business. In particular, Marie represents leading bio-pharma companies in litigation before the English and EU courts. Recently, Marie successfully represented both Laboratoires CTRS before the General Court in relation to the Commission’s refusal to grant a marketing authorisation for an orphan medicinal product (Case T-301/12); and Seattle Genetics Inc. in an SPC case before the Court of Justice (C-471/12); as well as Shire Pharmaceuticals which secured a Paediatric extension. Marie also regularly co-ordinates EU and overseas litigation. Marie is also representing Les Laboratoires Servier against a decision of the EU Commission for breach of competition rules, as well as representing them in a damage action before the English Courts.
 

Marie also represents pharma companies before UK and EU institutions (EMA, MHRA, NICE, PMCPA DOH and the European Commission). For example, Marie successfully represented Clinuvel Pharmaceuticals before the EMA in relation to their application for SCENESSE®, a breakthrough drug. Marie is Chairperson of the Legal Affairs Community for DIA. Marie is considered as a leading practitioner for regulatory law and is described by clients as a “regulatory superstar”. She is recommended in Legal 500, Chambers and Partners; also London Top 100 & London Top 50Women and EU Law & Super Lawyers UK (2013).

Maria Isabel is a Partner and head of the IP Regulatory Department at Bristows LLP. She specialises in European and UK regulatory and competition law in the bio-pharmaceutical and medical devices sectors.
 

She advises on a broad spectrum of matters, both contentious and noncontentious,
that arise in the conduct of a pharmaceutical or a biotechnology business. In particular, Marie represents leading bio-pharma companies in litigation before the English and EU courts. Recently, Marie successfully represented both Laboratoires CTRS before the General Court in relation to the Commission’s refusal to grant a marketing authorisation for an orphan medicinal product (Case T-301/12); and Seattle Genetics Inc. in an SPC case before the Court of Justice (C-471/12); as well as Shire Pharmaceuticals which secured a Paediatric extension. Marie also regularly co-ordinates EU and overseas litigation. Marie is also representing Les Laboratoires Servier against a decision of the EU Commission for breach of competition rules, as well as representing them in a damage action before the English Courts.
 

Marie also represents pharma companies before UK and EU institutions (EMA, MHRA, NICE, PMCPA DOH and the European Commission). For example, Marie successfully represented Clinuvel Pharmaceuticals before the EMA in relation to their application for SCENESSE®, a breakthrough drug. Marie is Chairperson of the Legal Affairs Community for DIA. Marie is considered as a leading practitioner for regulatory law and is described by clients as a “regulatory superstar”. She is recommended in Legal 500, Chambers and Partners; also London Top 100 & London Top 50Women and EU Law & Super Lawyers UK (2013).